Open AccessA commentary on “PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron”
Author(s) -
Muthu Sakthijothi,
Venkatesh Sundararajan
Publication year - 2022
Publication title -
clinical and translational discovery
Language(s) - English
Resource type - Journals
ISSN - 2768-0622
DOI - 10.1002/ctd2.87
Subject(s) - pi3k/akt/mtor pathway , virology , covid-19 , viral replication , disease , pandemic , in vitro , coronavirus , computational biology , biology , medicine , virus , bioinformatics , genetics , infectious disease (medical specialty) , signal transduction , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom